Manufacturing

Webinar Date/Time: Friday, May 19, 2023 at 11am EDT| 10am CDT | 8am PDT

Gregor Kawaletz, head of Oral Solid Dose Business Unit at Recipharm, discusses the immediate future of oral biologics

Bob Girton, partner at Edgewater, discusses best practices for how pharma manufactures should incorporate sustainability into their operations.

Avid Bioservices has launched new CGMP mammalian cell manufacturing suites at its Myford, Calif., facility.

The construction will expand Catalent’s clinical supply facility in Schorndorf, Germany.

Monil Malhotra, vice-president of Industrial Software at Emerson, discusses the growing demand for software solutions in the pharma industry.

Ginkgo Bioworks has acquired StrideBio's AAV capsid discovery and engineering platform and has formed a partnership with WARF for development of next-gen cell therapies.

The combination of modular facilities and closed processing offers significant advantages in the production of biopharmaceuticals and is becoming a compelling option for manufacturing.

Michalle Adkins, director of Life Sciences Consulting at Emerson, discusses the structure of manufacturing organizations and how novel technologies may play a role in operations.

Forecyte Bio has opened a new GMP facility in Shanghai just two months after its sister site in the United States.

The new site will include state-of-the-art cleanroom facilities, laboratories, R&D, and office spaces.

Webinar Date/Time: Friday, April 28, 2023 at 11am EDT | 10am CDT | 8am PDT

Claudio Fayad, VP of Technology, Process Systems, and Solutions discusses the intersection of automation and data security in the pharma industry.

Lonza and ABL Bio are collaborating on the development and manufacture of bispecific antibody product.

NextPharma has acquired a leading European chewable tablets manufacturing site from Takeda in Asker, Norway.

Nathan Pettus, president of Process Systems and Solutions at Emerson, discusses how automation is impacting recent sustainability technologies and solutions.

Sartorius’ acquisition of Polyplus is designed to strengthen its cell and gene therapy capabilities.

Interviews hosted on-site at the Emerson Automation Exchange in Grapevine, Texas, from October 24th to October 28th, 2022.

Mass spectrometric techniques are providing insights in critical RNA-based therapeutic areas.

A CPHI North America panel discussion forewarns that CDMO supply chains are potentially the biggest single risk to product resilience.

Webinar Date/Time: Tue, May 23, 2023 11:00 AM EDT

As new manufacturing processes and technologies are introduced to meet demand and overcome challenges, understanding also needs to improve to ensure the right balance is achieved.

Impurities and batch-to-batch variability present the biggest challenges.

Limitations in production platforms have impeded continuous manufacturing for advanced therapies.

Manufacturers and suppliers join forces to reduce the pharmaceutical industry’s carbon footprint.